ECM
EVH icon

ExodusPoint Capital Management’s Evolent Health EVH Stock Holding History

ExodusPoint Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200,000
Closed -$6.2M – 2280
2021
Q3 		$6.2M Buy
+200,000
New +$4.8M 0.08% 327

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ExodusPoint Capital Management's EVH Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Evolent Health (EVH) stake by 9.6% in Q1 2026, selling an estimated $5.03K and leaving 14,983 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

ExodusPoint Capital Management first reported a position in EVH in Q2 2019 and has held it in 15 quarters since. The position peaked at $1.23M in Q2 2022. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • ExodusPoint Capital Management held 14,983 shares of Evolent Health worth $34.2K as of Q1 2026.
  • ExodusPoint Capital Management sold 1,586 Evolent Health shares in Q1 2026, an estimated $5.03K.
  • Evolent Health made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1465 holding.
  • ExodusPoint Capital Management first reported a position in Evolent Health in Q2 2019 and has held it in 15 quarters since.
  • ExodusPoint Capital Management's Evolent Health position peaked at $1.23M in Q2 2022.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.